LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular” or the “Company”) (OTCBB: IMUC) announced today that Dr. Richard Chin has been elected to the Company’s Board of Directors and appointed as Chairman of the Company’s Compensation Committee and as a member of the Company’s Audit Committee. Dr. Chin currently serves on the Adjunct Faculty of the University of California, San Francisco School of Medicine, and on the Board of Directors of Genmedica Therapeutics S.L., Balance Therapeutics , Inc., and Galena Biopharma, Inc. (NASDAQ: GALE).
